GGrantIndex
← Search

CORE--NUDE/SCID MOUSE FACILITY

$167,178P30FY2002CANIH

University Of California Los Angeles, Los Angeles CA

Investigators

Linked publications, trials & patents

Trial NCT07339085Trial NCT07276438Trial NCT07242365Trial NCT06650163Trial NCT06568016Trial NCT06113016Trial NCT05595499Trial NCT04205838Trial NCT04201873Trial NCT04185311Trial NCT04119024Trial NCT04106362Trial NCT04069923Trial NCT04069910Trial NCT04050215Trial NCT04007029Trial NCT03996850Trial NCT03970252Trial NCT03953157Trial NCT03904251Trial NCT03902951Trial NCT03892720Trial NCT03830918Trial NCT03825796Trial NCT03745690Trial NCT03732950Trial NCT03732352Trial NCT03672773Trial NCT03623854Trial NCT03618134Trial NCT03603223Trial NCT03601455Trial NCT03596710Trial NCT03582774Trial NCT03582475Trial NCT03541850Trial NCT03515577Trial NCT03506802Trial NCT03425461Trial NCT03411070Trial NCT03368547Trial NCT03319342Trial NCT03240861Trial NCT03202472Trial NCT03128619Trial NCT03025139Trial NCT03014804Trial NCT02940262Trial NCT02928510Trial NCT02925351Trial NCT02919332Trial NCT02902757Trial NCT02888301Trial NCT02881242Trial NCT02880020Trial NCT02879994Trial NCT02830165Trial NCT02816879Trial NCT02775292Trial NCT02756130Trial NCT02701153Trial NCT02688348Trial NCT02683200Trial NCT02672033Trial NCT02597894Trial NCT02575027Trial NCT02451865Trial NCT02336763Trial NCT02310594Trial NCT02296229Trial NCT02280161Trial NCT02263898Trial NCT02176902Trial NCT02070406Trial NCT02049593Trial NCT02048020Trial NCT02015559Trial NCT01912820Trial NCT01013285Trial NCT01005472Trial NCT00999557Trial NCT00998010Trial NCT00985192Trial NCT00955591Trial NCT00882765Trial NCT00880542Trial NCT00769470Trial NCT00706615Trial NCT00685516Trial NCT00616642Trial NCT00612066Trial NCT00601289Trial NCT00601094Trial NCT00521209Trial NCT00509431Trial NCT00471887Trial NCT00450567Trial NCT00444223Trial NCT00352001Trial NCT00349167

Abstract

Description: Immunodeficient mice are being used as a means to grow both normal and transformed cells and/or tissues in vivo. Athymic mice (nu/nu, Balb background) and severe combined immunodeficient (SCID, C.B.-17 scid/scid) mice are being utilized. The resource provides mice for cancer-related studies, housing and maintenance of animals, and resource personnel to facilitate in vivo experiments. Biosafety Level (BSL) 2 and 3 facilities are available within the resource. The shared resource is located in two separate animal facilities, both under the jurisdiction of the Campus Veterinarian and accredited by the American Association for the Accreditation of Laboratory Animal Care (AAALAC). The second floor of Warren Hall contains three rooms used by the shared resource. A 600 sq. ft. room is used for housing colonies of nudes and SCIDs, for surgical procedures to implant human fetal tissues into SCID mice, and for housing experimental mice. The other two rooms of this facility house experimental animals. One room of 300 sq. ft. is used for BSL 2 studies and can house 175 cages of SCID mice. The facility is used exclusively for cancer-related research. Current studies include oncogenesis, metastasis, and gene transfer with replication-defective vectors. The BSL 3 Facility is 400 sq. ft. and capable of housing 150 mouse cages. It is used to house SCIDhuman mice infected with human retroviruses. A portion of the studies in this facility are cancer related, the rest are AIDS related. Current Center-supported studies include in vivo models of HTLV-induced leukemogenesis. The Core SCID breeding colony is housed in the Center for Health Sciences. Access to the colony is limited to individuals trained in animal husbandry. At present, 30 nu/nu breeding sets are maintained with production of 30-40 pups per month. The SCID facility maintains 75 breeding pairs and produces 250 SCID pups per month. Weaned SCIDS from the core breeding facility are transferred to the Warren Hall facility for use in experiments. Animals in both facilities are maintained under microisolation. As an added precaution, SCID and breeding nude mice are housed in laminar flow racks.

View original record on NIH RePORTER →